These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7895949)

  • 1. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.
    Vettor R; Zarjevski N; Cusin I; Rohner-Jeanrenaud F; Jeanrenaud B
    Diabetologia; 1994 Dec; 37(12):1202-8. PubMed ID: 7895949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle.
    Zarjevski N; Cusin I; Vettor R; Rohner-Jeanrenaud F; Jeanrenaud B
    Diabetes; 1994 Jun; 43(6):764-9. PubMed ID: 8194661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue.
    Sainsbury A; Cusin I; Doyle P; Rohner-Jeanrenaud F; Jeanrenaud B
    Diabetologia; 1996 Mar; 39(3):353-6. PubMed ID: 8721783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.
    Baran K; Preston E; Wilks D; Cooney GJ; Kraegen EW; Sainsbury A
    Diabetes; 2002 Jan; 51(1):152-8. PubMed ID: 11756335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous neuropeptide Y on insulin secretion and insulin sensitivity in skeletal muscle in normal rats.
    Vettor R; Pagano C; Granzotto M; Englaro P; Angeli P; Blum WF; Federspil G; Rohner-Jeanrenaud F; Jeanrenaud B
    Diabetologia; 1998 Nov; 41(11):1361-7. PubMed ID: 9833945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin.
    van den Hoek AM; Voshol PJ; Karnekamp BN; Buijs RM; Romijn JA; Havekes LM; Pijl H
    Diabetes; 2004 Oct; 53(10):2529-34. PubMed ID: 15448080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat.
    Wang Q; Bing C; Al-Barazanji K; Mossakowaska DE; Wang XM; McBay DL; Neville WA; Taddayon M; Pickavance L; Dryden S; Thomas ME; McHale MT; Gloyer IS; Wilson S; Buckingham R; Arch JR; Trayhurn P; Williams G
    Diabetes; 1997 Mar; 46(3):335-41. PubMed ID: 9032086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity.
    Zarjevski N; Cusin I; Vettor R; Rohner-Jeanrenaud F; Jeanrenaud B
    Endocrinology; 1993 Oct; 133(4):1753-8. PubMed ID: 8404618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue.
    Rouru J; Cusin I; Zakrzewska KE; Jeanrenaud B; Rohner-Jeanrenaud F
    Endocrinology; 1999 Aug; 140(8):3688-92. PubMed ID: 10433228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats.
    Sainsbury A; Cusin I; Rohner-Jeanrenaud F; Jeanrenaud B
    Diabetes; 1997 Feb; 46(2):209-14. PubMed ID: 9000696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between adrenal glucocorticoids and parasympathetic activation in mediating hyperinsulinaemia during long-term central neuropeptide Y infusion in rats.
    Sainsbury A; Wilks D; Cooney GJ
    Diabetologia; 2000 Jul; 43(7):859-65. PubMed ID: 10952458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.
    Sainsbury A; Rohner-Jeanrenaud F; Cusin I; Zakrzewska KE; Halban PA; Gaillard RC; Jeanrenaud B
    Diabetologia; 1997 Nov; 40(11):1269-77. PubMed ID: 9389418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
    Schwartz MW; Sipols AJ; Marks JL; Sanacora G; White JD; Scheurink A; Kahn SE; Baskin DG; Woods SC; Figlewicz DP
    Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.
    Bing C; King P; Pickavance L; Brown M; Ziegler D; Kaan E; Williams G
    Br J Pharmacol; 1999 May; 127(1):35-42. PubMed ID: 10369453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.
    Catzeflis C; Pierroz DD; Rohner-Jeanrenaud F; Rivier JE; Sizonenko PC; Aubert ML
    Endocrinology; 1993 Jan; 132(1):224-34. PubMed ID: 8380374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.
    Pierroz DD; Catzeflis C; Aebi AC; Rivier JE; Aubert ML
    Endocrinology; 1996 Jan; 137(1):3-12. PubMed ID: 8536627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vanadium on insulin sensitivity and appetite.
    Wang J; Yuen VG; McNeill JH
    Metabolism; 2001 Jun; 50(6):667-73. PubMed ID: 11398143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.
    Stafford JM; Yu F; Printz R; Hasty AH; Swift LL; Niswender KD
    Diabetes; 2008 Jun; 57(6):1482-90. PubMed ID: 18332095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and orexigenic effects of intracerebroventricular neuropeptide Y are attenuated by food deprivation.
    Parikh R; Marks JL
    J Neuroendocrinol; 1997 Oct; 9(10):789-95. PubMed ID: 9355048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic consequences of neuropeptide Y-induced obesity.
    Correia ML; Morgan DA; Sivitz WI; Mark AL; Haynes WG
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):137-42. PubMed ID: 11865825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.